# Outcomes of Esophageal Self Dilation for Benign Refractory Esophageal Stricture Management

> **NCT03738566** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 26 (actual)

## Conditions studied

- Esophageal Dilation
- Refractory Benign Esophageal Stricture

## Interventions

- **DEVICE:** Esophageal self-dilation therapy
- **PROCEDURE:** Endoscopic therapy with esophageal dilation

## Key facts

- **NCT ID:** NCT03738566
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-21
- **Primary completion:** 2021-07-02
- **Final completion:** 2022-05-15
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2023-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03738566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03738566, "Outcomes of Esophageal Self Dilation for Benign Refractory Esophageal Stricture Management". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03738566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*